A study to investigate genetic factors associated with weight gain in people with diabetes: analysis of polymorphisms in four relevant genes

References

• https://www.diabetes.co.uk/cost-of-diabetes.html; Accessed 14 March 2023.
   Google Scholar
• Bonadonna RC, De Fronzo RA. Glucose metabolism in obesity and type 2 diabetes. Diabete Metab. 1991 May;17(1 Pt 2):112–9.
   PubMedGoogle Scholar
• Leitner DR, Frühbeck G, Yumuk V, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies - EASO can lead the way. Obes Facts. 2017[Epub 2017 Oct 12];10(5):483–492. doi: 10.1159/000480525
   PubMed Web of Science ®Google Scholar
• Kivimäki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022 Apr [Epub 2022 Mar 4];10(4):253–263. doi: 10.1016/S2213-8587(22)00033-X
   PubMed Web of Science ®Google Scholar
• Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022 Feb [Epub 2021 Sep 23];23(2):120–133. doi: 10.1038/s41576-021-00414-z
   PubMed Web of Science ®Google Scholar
• Ludwig-Słomczyńska AH, Seweryn MT, Kapusta P, et al. The transcriptome-wide association search for genes and genetic variants which associate with BMI and gestational weight gain in women with type 1 diabetes. Mol Med. 2021 Jan 20;27(1):6. doi: 10.1186/s10020-020-00266-z
   PubMed Web of Science ®Google Scholar
• McCaffery JM, Papandonatos GD, Huggins GS, et al. FTO predicts weight regain in the Look AHEAD clinical trial. Int J Obes (Lond). 2013 Dec[Epub 2013 Apr 3];37(12):1545–1552. doi: 10.1038/ijo.2013.54
   PubMed Web of Science ®Google Scholar
• Yang MM, Wang J, Fan JJ, et al. Variations in the obesity gene “LEPR” contribute to risk of type 2 diabetes mellitus: evidence from a meta-analysis. J Diabetes Res. 2016 [Epub 2016 Apr 18];2016:5412084. doi: 10.1155/2016/5412084
   PubMedGoogle Scholar
• Gorska E, Popko K, Stelmaszczyk-Emmel A, et al. Leptin receptors. Eur J Med Res. 2010 Nov 4;15(Suppl 2):50–54. doi: 10.1186/2047-783x-15-s2-50
   PubMedGoogle Scholar
• Aller R, Primo Martín D, Izaola O, et al. Association of the leptin receptor rs 1805134 polymorphism with obesity parameters, dietary intakes, and metabolic syndrome in Caucasian obese subjects. Nutrición Hospitalaria. 40(1): English:35–40. 2023 Feb 15. 10.20960/nh.04139
   PubMedGoogle Scholar
• Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998 Mar 26;392(6674):398–401. doi: 10.1038/32911
   PubMed Web of Science ®Google Scholar
• Sun Q, van Dam RM, Meigs JB, et al. Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes. [Epub 2009 Dec 3] 2010 Mar 59(3):611–618. doi: 10.2337/db09-1343
   PubMed Web of Science ®Google Scholar
• Daghestani MH, Daghestani MH, Daghistani MH, et al. The influence of the rs1137101 genotypes of leptin receptor gene on the demographic and metabolic profile of normal Saudi females and those suffering from polycystic ovarian syndrome. BMC Womens Health. 2019 Jan 11;19(1). doi: 10.1186/s12905-018-0706-x
   PubMedGoogle Scholar
• Parat MO. The biology of caveolae: achievements and perspectives. Int Rev Cell Mol Biol. 2009;273:117–162. doi: 10.1016/S1937-6448(08)01804-2
   PubMed Web of Science ®Google Scholar
• Baudrand R, Gupta N, Garza AE, et al. Caveolin 1 modulates aldosterone-mediated pathways of glucose and lipid homeostasis. J Am Heart Assoc. 2016 Sep 28;5(10):e003845. doi: 10.1161/JAHA.116.003845
   PubMed Web of Science ®Google Scholar
• Yates A, Akanni W, Amode MR, et al. Ensembl 2016. Nucleic Acids Res. 2016 Jan 4Epub 2015 Dec 19;44(D1):D710–6. doi: 10.1093/nar/gkv1157
   PubMed Web of Science ®Google Scholar
• Rosas-Vargas H, Martínez-Ezquerro JD, Bienvenu T. Brain-derived neurotrophic factor, food intake regulation, and obesity. Arch Med Res. [Epub 2011 Sep 22] 2011 Aug 42(6):482–494. doi: 10.1016/j.arcmed.2011.09.005
   PubMed Web of Science ®Google Scholar
• Nakazato M, Hashimoto K, Shimizu E, et al. Possible involvement of brain-derived neurotrophic factor in eating disorders. IUBMB Life. 2012 May[Epub 2012 Apr 4];64(5):355–361. doi: 10.1002/iub.1012
   PubMed Web of Science ®Google Scholar
• Rozanska O, Uruska A, Zozulinska-Ziolkiewicz D. Brain-derived neurotrophic factor and diabetes. Int J Mol Sci. 2020 Jan 28;21(3):841. doi: 10.3390/ijms21030841
   PubMed Web of Science ®Google Scholar
• Chen ZY, Patel PD, Sant G, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 2004 May 5;24(18):4401–4411. doi: 10.1523/JNEUROSCI.0348-04.2004
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003 Jan 24;112(2):257–269. doi: 10.1016/s0092-8674(03)00035-7
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007 May 11Epub 2007 Apr 12;316(5826):889–894. doi: 10.1126/science.1141634
   PubMed Web of Science ®Google Scholar
• Rendo T, Moleres A, Marti Del Moral A. Effects of the FTO gene on lifestyle intervention studies in children. Obes Facts. 2009 Epub 2009 Dec 10;2(6):393–399. doi: 10.1159/000262296
   PubMed Web of Science ®Google Scholar
• Tercjak M, Luczyński W, Wawrusiewicz-Kurylonek N, et al. Rola polimorfizmu genu FTO w patogenezie otyłości [The role of FTO gene polymorphism in the pathogenesis of obesity]. Pediatr Endocrinol Diabetes Metab. 2010;16(2): 109–113. Polish.
   PubMedGoogle Scholar
• Koike S, Richards M, Wong A, et al. Fat mass and obesity-associated (FTO) rs9939609 polymorphism modifies the relationship between body mass index and affective symptoms through the life course: a prospective birth cohort study. Transl Psychiatry. 2018 Mar 13;8(1):62. doi: 10.1038/s41398-018-0110-1
   PubMedGoogle Scholar
• Zhao X, Yang Y, Sun BF, et al. FTO and obesity: mechanisms of association. Curr Diab Rep. 2014;14(5):486. doi: 10.1007/s11892-014-0486-0
   PubMed Web of Science ®Google Scholar
• https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics Accessed25 March 2023
   Google Scholar
• https://www.diabetesgenes.org/current-research/dare/: Accessed 25 March 2023
   Google Scholar
• https://gmwearebettertogether.com/: Accessed 25 March 2023
   Google Scholar
• Baudrand R, Goodarzi MO, Vaidya A, et al. A prevalent caveolin-1 gene variant is associated with the metabolic syndrome in Caucasians and Hispanics. Metabolism. [Epub 2015 Sep 12] 2015 Dec 64(12):1674–1681. doi: 10.1016/j.metabol.2015.09.005
   PubMed Web of Science ®Google Scholar
• Chang CC, Chen CY, Wen HC, et al. Caveolin-1 secreted from adipose tissues and adipocytes functions as an adipogenesis enhancer. Obesity (Silver Spring). [Epub 2017 Sep 25] 2017 Nov 25(11):1932–1940. doi: 10.1002/oby.21970
   PubMed Web of Science ®Google Scholar
• Li H, Wang X, Zhou Y, et al. Association of LEPR and ANKK1 gene polymorphisms with weight gain in epilepsy patients receiving valproic acid. Int J Neuropsychopharmacol. 2015 Mar 3;18(7):yv021. doi: 10.1093/ijnp/pyv021
   Web of Science ®Google Scholar
• Almandil NB, Lodhi RJ, Ren H, et al. Associations between the LEP -2548G/A promoter and baseline weight and between LEPR Gln223Arg and Lys656Asn Variants and Change in BMI z Scores in Arab Children and Adolescents Treated with Risperidone. Mol Neuropsychiatry. 2018 Oct [Epub 2018 Oct 5];4(2):111–117. doi: 10.1159/000490463
   PubMedGoogle Scholar
• https://www.ukbiobank.ac.uk/; Accessed 5th May 2023
   Google Scholar